Patient autonomy and distributive justice are fundamental ethical principles that may be at risk in liver transplant units where decisions are dictated by the need to maximise the utility of scarce donor organs. The processes of patient selection, organ allocation and prioritisation on the wait list have evolved in a constrained environment, leading to high levels of complexity and low transparency. Regarding paternalism, opaque listing and allocation criteria, patient factors such as passivity, guilt, chronic illness and sub-clinical encephalopathy are cited as factors that may inhibit patient engagement. Regarding justice, established regional, gender and race based inequities are described. The paradox whereby hepatologists both advocate for individual patients and discharge their duty of stewardship to apportion organs according to larger utilitarian principles is explored. Competing subjective factors such as physicians’ perception of moral responsibility, the qualitative nature of expert medical assessment and institutional or personal loyalty to re-transplantation candidates are described. Realistic limits of self-determination and justice are discussed, and possible future directions in terms of patient involvement proposed.
CroninDCCroninTM.Twenty years of Milan criteria and live-donor liver transplantation in the US: a contrast in transparency, regulation, and expectation. Hepatobiliary Surg Nutr2016;
5: 495–497.
2.
LeeEJohnstonCJCOniscuGC.The trials and tribulations of liver allocation. Transpl Int2020; 33: 1343–1352.
3.
ThorntonV.Who gets the liver transplant? The use of responsibility as the tie breaker. J Med Ethics2009;
35: 739–742.
4.
DonckierVLucidiVGustotT, et al.
Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy. J Hepatol2014;
60: 866–871.
5.
LeeBPTerraultNA.Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant2018;
23: 229–236.
6.
BeauchampTLC.Principles of Biomedical Ethics. 5th edn.Oxford, UK:
Oxford University Press, 2001.
7.
GillonR.Medical ethics: four principles plus attention to scope. BMJ1994;
309: 184–188.
8.
EghtesadBBronstherOIrishW, et al.
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology1994;
20: 56S–62S.
9.
RatcliffeJBuxtonMYoungT, et al.
Determining priority for liver transplantation: a comparison of cost per QALY and discrete choice experiment-generated public preferences. Appl Health Econ Health Policy2005;
4: 249–255.
UbelPALoewensteinG.Distributing scarce livers: the moral reasoning of the general public. Soc Sci Med1996;
42: 1049–1055.
12.
VolkMLVijanSMarreroJA.A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant2008;
8: 839–846.
13.
BenthamJ.An Introduction to the Principles of Morals and Legislation.
Garden City, NY:
Dover Publications, 2007.
14.
MillJS.Utilitarianism.
Cambridge, UIK:
Cambridge University Press, 2014.
15.
FreemanRBBernatJL.Ethical issues in organ transplantation. Prog Cardiovasc Dis2012;
55: 282–289.
16.
DworkinG.“Paternalism”, The Stanford Encyclopedia of Philosophy (Fall 2020 Edition). In: Zalta EN (ed.). Stanford University, Metaphysics Research Lab.
17.
HallidayNWestbrookRH.Liver transplantation: need, indications, patient selection and pre-transplant care. Br J Hosp Med (Lond)2017;
78: 252–259.
18.
NeubergerJJamesO.Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet1999;
354: 1636–1639.
19.
AlaliJRamjiAHoJK, et al.
Liver transplant candidacy unsuitability: a review of the British Columbia experience. Can J Gastroenterol2006;
20: 95–99.
20.
MillsonCConsidineACrampME, et al.
Adult liver transplantation: a UK clinical guideline – part 1: pre-operation. Frontline Gastroenterol2020;
11: 375–384.
21.
Shahabeddin PariziAKrabbePFMBuskensE, et al.
Health items with a novel patient-centered approach provided information for preference-based transplant outcome measure. J Clin Epidemiol2020;
126: 93–105.
22.
JonassonO.Waiting in line: should selected patients ever be moved up?Transplant Proc1989;
21: 3390–3394; discussion 3413–3398.
23.
HiroseRHeimbachJ.Defining disparities in liver transplantation: the devil is in the details. Liver Transpl2017;
23: 557–558.
24.
MathurAKSchaubelDEZhangH, et al.
Disparities in liver transplantation: the association between donor quality and recipient race/ethnicity and sex. Transplantation2014;
97: 862–869.
25.
AnanthakrishnanANSaeianK.Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol2008;
103: 901–910.
26.
LockeJESheltonBAOlthoffKM, et al.
Quantifying sex-based disparities in liver allocation.JAMA Surg2020;
155: e201129.
27.
CholankerilGYooERPerumpailRB, et al.
Disparities in liver transplantation resulting from variations in regional donor supply and multiple listing practices. Clin Gastroenterol Hepatol2017;
15: 313–315.
28.
KulkarniSCroninDC.Ethics in liver transplantation. Semin Liver Dis2006;
26: 234–238.
29.
NorthupPGIntagliataNMShahNL, et al.
Excess mortality on the liver transplant waiting list: unintended policy consequences and model for end-stage liver disease (MELD) inflation. Hepatology2015;
61: 285–291.
30.
HalpernSDShakedAHaszRD, et al.
Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med2008;
358: 2832–2837.
31.
DevlinJO’GradyJ.Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut1999;
45: VI1–VI22.
32.
NeubergerJGimsonADaviesM, et al. UK Blood and Transplant.
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut2008;
57: 252–257.
33.
Ferraz-NetoBHZurstrassenMPHidalgoR, et al.
Analysis of liver transplantation outcome in patients with MELD score > or = 30. Transplant Proc2008;
40: 797–799.
34.
ShemeshYPeles-BortzAPeledY, et al.
Feelings of indebtedness and guilt toward donor and immunosuppressive medication adherence among heart transplant (HTx) patients, as assessed in a cross-sectional study with the basel assessment of adherence to immunosuppressive medications scale (BAASIS). Clin Transplant2017;
31: e13053–e13012.
35.
GillPLowesL.Renal transplant failure and disenfranchised grief: participants’ experiences in the first year post-graft failure – a qualitative longitudinal study. Int J Nurs Stud2014;
51: 1271–1280.
NardoneRTaylorACHollerY, et al.
Minimal hepatic encephalopathy: a review. Neurosci Res2016;
111: 1–12.
38.
BigginsSWBambhaK.MELD-based liver allocation: who is underserved?Semin Liver Dis2006;
26: 211–220.
39.
KabrhelCCamargoCAJr.andGoldhaberSZ.Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?Chest2005;
127: 1627–1630.
40.
RunyonMSRichmanPBKlineJA; Pulmonary Embolism Research Consortium Study Group.Emergency medicine practitioner knowledge and use of decision rules for the evaluation of patients with suspected pulmonary embolism: variations by practice setting and training level. Acad Emerg Med2007;
14: 53–57.
41.
NeubergerJ.Public and professional attitudes to transplanting alcoholic patients. Liver Transpl2007;
13: S65–S68.
42.
NeubergerJAdamsDMacMasterP, et al.
Assessing priorities for allocation of donor liver grafts: survey of public and clinicians.BMJ1998;
317: 172–175.
43.
KrutliPRosemannTTornblomKY, et al.
How to fairly allocate scarce medical resources: ethical argumentation under scrutiny by health professionals and lay people.PLoS One2016;
11: e0159086.
44.
O’DellHWMcMichaelBJLeeS, et al.
Public attitudes toward contemporary issues in liver allocation. Am J Transplant2019;
19: 1212–1217.
45.
DixonJWelchHG.Priority setting: lessons from Oregon. Lancet1991;
337: 891–894.
46.
UbelPAJepsonCBaronJ, et al.
Allocation of transplantable organs: do people want to punish patients for causing their illness?Liver Transpl2001;
7: 600–607.
47.
TongAHowardKJanS, et al.
Community preferences for the allocation of solid organs for transplantation: a systematic review. Transplantation2010;
89: 796–805.
48.
Carina OedingenTBDierksM‐LMühlbacherAC, et al.
Public preferences for the allocation of donor organs for transplantation: focus group discussions. Health Expect2020;
23: 670–680.
49.
BartlingTOedingenCKohlmannT, et al.
Comparing preferences of physicians and patients regarding the allocation of donor organs: a systematic review. Transplant Rev (Orlando)2020;
34: 100515–102019.
50.
OedingenCBartlingTMuhlbacherAC, et al.
Systematic review of public preferences for the allocation of donor organs for transplantation: principles of distributive justice. Patient2019;
12: 475–489.
51.
HoD.When good organs go to bad people. Bioethics2008;
22: 77–83.
52.
MossAHSieglerM.Should alcoholics compete equally for liver transplantation?JAMA1991;
265: 1295–1298.
53.
DavisGLAlbrightJECookSF, et al.
Projecting future complications of chronic hepatitis C in the United States. Liver Transpl2003;
9: 331–338.
54.
GaneEJPortmannBCNaoumovNV, et al.
Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med1996;
334: 815–820.
55.
BerenguerMFerrellLWatsonJ, et al.
HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol2000;
32: 673–684.
56.
YooHYMaheshwariAThuluvathPJ.Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl2003;
9: 897–904.
57.
PelletierSJSchaubelDEPunchJD, et al.
Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl2005;
11: 434–440.
58.
RoayaieSSchianoTDThungSN, et al.
Results of retransplantation for recurrent hepatitis C. Hepatology2003;
38: 1428–1436.
59.
NeffGWO’BrienCBNeryJ, et al.
Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl2004;
10: 1497–1503.
60.
UbelPAArnoldRMCaplanAL.Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA1993;
270: 2469–2474.
61.
FormanLM.To transplant or not to transplant recurrent hepatitis C and liver failure. Clin Liver Dis2003;
7: 615–629.
62.
McCashlandTWattKLydenE, et al.
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl2007;
13: 1246–1253.
63.
BurtonJRJr.SonnenbergARosenHR.Retransplantation for recurrent hepatitis C in the MELD era: maximizing utility. Liver Transpl2004;
10: S59–S64.
64.
KamathPSWiesnerRHMalinchocM, et al.
A model to predict survival in patients with end-stage liver disease. Hepatology2001;
33: 464–470.
65.
UnitedS.National organ transplant act: Public law 98-507. US Statut Large1984;
98: 2339–2348.
66.
TenorioALMacedoFIMirandaLE, et al.
Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score. Transplant Proc2010;
42: 407–411.
67.
GimsonA.Development of a UK liver transplantation selection and allocation scheme. Curr Opin Organ Transplant2020;
25: 126–131.
